Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Ligand Pharmaceuticals
LGND
Segment Reporting Other Item Amount
Segment Reporting Other Item Amount at other companies
Equitable Holdings
EQH
$371M
-5.1%
Essential Utilities
WTRG
-$75K
+74.4%
Protagonist Therapeutics
PTGX
-$53K
+35.4%
Paylocity
PCTY
$57.07M
-6.4%
IPG Photonics
IPGP
$11.67M
+968%
Remitly Global, Inc.
RELY
$881K
+140%
Segments
By segment
See full
Development and Licensing of Biopharmaceutical Assets
$51.16M
-29.0%
Other financials
Income statement
See full
Revenue
$51.7M
+14.1%
Operating income
$17.4M
+148%
Net income
-$13.3M
+68.6%
EPS (diluted)
-$0.67
+69.7%
Balance sheet
See full
Cash & equivalents
$115.1M
+140%
Total debt
$5.1M
+14.2%
Total equity
$997.3M
+25.4%
Total assets
$1.5B
+69.2%
Cash flow
See full
Operating cash flow
$48.7M
+291%
CapEx
$228.0K
+6.5%
Free cash flow
$48.5M
+289%
Valuation
See full
Market cap
$5.51B
+96.7%
Enterprise value
$5.4B
+95.4%
P/E
35.9×
—
P/S
20.1×
+4.6×
Profitability
See full
Gross margin
91.9%
—
Operating margin
34.5%
+23.0pp
Net margin
55.9%
+35.7pp
FCF margin
44.8%
+16.8pp
Returns & leverage
See full
Return on equity
17.1%
+11.5pp
Debt / equity
0×
0.0×
Current ratio
21.3×
+16.0×
